Sergliflozin etabonate

Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.

408504-26-7

≥ 2 years

>98% (HPLC)

448.468

C23H28O9

Research use only, not for human use.

Protoporphyrinogen oxidase

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBL1-16701 0.1 mg

Ask

MBS8577640-01 0.1 mL

Ask

MBS8577640-02 0.1 mL (AF405L)

Ask

MBS8577640-03 0.1 mL (AF405S)

Ask

MBS8577640-04 0.1 mL (AF610)

Ask

MBS8577640-05 0.1 mL (AF635)

Ask